Emerging Southeast Asian PfCRT mutations confer Plasmodium falciparum resistance to the first-line antimalarial piperaquine
Leila S. Ross(Columbia University Irving Medical Center), David A. Fidock(Columbia University Irving Medical Center)
Cited by 270
Related Papers
Globally prevalent PfMDR1 mutations modulate Plasmodium falciparum susceptibility to artemisinin-based combination therapies
|Nature Communications|2016|350
Atherosclerosis Is a Smooth Muscle Cell–Driven Tumor-Like Disease
|Circulation|2024|119
Genetic screens reveal a central role for heme metabolism in artemisinin susceptibility
|Nature Communications|2020|76